BISOGNI, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.056
EU - Europa 280
AS - Asia 153
OC - Oceania 2
SA - Sud America 2
Totale 2.493
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.055
CN - Cina 130
IT - Italia 123
SE - Svezia 53
GB - Regno Unito 33
FI - Finlandia 27
DE - Germania 21
IN - India 10
NL - Olanda 7
UA - Ucraina 7
VN - Vietnam 5
IE - Irlanda 4
SG - Singapore 4
HK - Hong Kong 3
AU - Australia 2
PE - Perù 2
DK - Danimarca 1
FR - Francia 1
IQ - Iraq 1
MX - Messico 1
PL - Polonia 1
RS - Serbia 1
SI - Slovenia 1
Totale 2.493
Salva come PNG Salva come JPEG
Città #
Fairfield 398
Chandler 225
Woodbridge 220
Houston 152
Seattle 152
Ashburn 143
Cambridge 135
Ann Arbor 117
Wilmington 116
Padova 49
San Diego 39
Beijing 36
Medford 34
Princeton 34
New York 32
Des Moines 28
Guangzhou 21
Boardman 20
Roxbury 20
Nanjing 16
Helsinki 15
Jinan 9
Shanghai 9
Milan 6
Dong Ket 5
Dublin 4
Kharkiv 4
Norwalk 4
Rome 4
Hebei 3
Jiaxing 3
Lanzhou 3
London 3
Ningbo 3
Orange 3
Pontecchio Polesine 3
Shenyang 3
Tianjin 3
Vicenza 3
Amsterdam 2
Baiano 2
Bergamo 2
Buffalo 2
Haikou 2
Hangzhou 2
Islington 2
Lima 2
Petershagen 2
Taizhou 2
Villorba 2
Belgrade 1
Brescia 1
Cardiff 1
Castelnuovo di Val di Cecina 1
Changsha 1
Chiswick 1
Chongqing 1
El Paso 1
Esslingen am Neckar 1
Indiana 1
Kherson 1
Kongens Lyngby 1
Kunming 1
Lishui 1
Mahbubnagar 1
Nanchang 1
Napoli 1
New Delhi 1
Ogden 1
Paris 1
Pune 1
Redmond 1
Redwood City 1
Sacramento 1
Singapore 1
Stockholm 1
Sydney 1
Taiyuan 1
Verona 1
Zhengzhou 1
Totale 2.129
Salva come PNG Salva come JPEG
Nome #
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 166
Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy 129
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 128
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 113
Epicardial fat thickness in patients with autosomal dominant polycystic kidney disease. 105
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 103
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 101
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 90
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 86
The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism 85
Apparent mineralcorticoid excess syndrome, an often forgotten or unrecognized cause of hypokalemia and hypertension: Case report and appraisal of the pathophysiology. 84
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 84
A rare case report of hypertrophic cardiomyopathy induced by catecholamine-producing tumor 83
Cure with cryoablation of arterial hypertension due to a renin-producing tumor. 82
An App for the Diagnosis of Primary Aldosteronism 76
Atrial fibrillation as presenting sign of primary aldosteronism: Results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study 72
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 67
Analysis of short-term blood pressure variability in pheochromocytoma/paraganglioma patients. 67
Prevalence of peri-implant diseases among an Italian population of patients with metabolic syndrome: a cross-sectional study. 64
A useful tool to improve the case detection rate of primary aldosteronism: The aldosterone -renin ratio (ARR)-App 64
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 63
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 62
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 62
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 59
Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals. 58
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 55
Munchausen syndrome: a novel cause of drug-resistant hypertension. 54
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 52
Recent advances in the diagnosis and management of obstructive sleep apnea 51
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 41
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 36
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 34
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 34
The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea 21
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 19
Totale 2.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.179
article - articoli 9.179
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019140 0 0 0 0 0 0 0 0 0 0 70 70
2019/2020586 53 30 9 73 58 32 59 56 92 59 49 16
2020/2021516 24 17 21 21 20 9 60 29 53 108 33 121
2021/2022491 24 39 26 47 28 54 39 41 25 23 26 119
2022/2023411 69 48 33 41 74 41 4 30 43 8 16 4
2023/2024180 13 26 25 18 7 40 13 4 11 23 0 0
Totale 2.550